Login / Signup
Getting the Timing Right: Controlling BCL-2 Inhibition as an Anti-Fibrotic Therapy.
Joseph C Cooley
Elizabeth F Redente
Published in:
American journal of respiratory cell and molecular biology (2024)
Keyphrases
</>
systemic sclerosis
idiopathic pulmonary fibrosis
stem cells
mesenchymal stem cells